April 7th, 2016.
Subject 15 took 5 pills Quickhelper pills every day for a month. Initial response started to stabilize after a week of use. After this span of time, it appeared consistently, an hour after consuming the dose, with expected results. Heart rate stabilized. Anxiety decreaced.
We tested how the pills work long-term. We gave eight subjects three doses every day for a month and reported the effect. The subjects stayed in the same habitat the whole period, and were fed tube meals and water. They stayed completely healthy, but now we are looking at their mental state.
After two weeks of use, at approximately 2 hours after consumation, subject 3 began reporting difficulty with voluntary movement. We gave her a simple task, which was to move a block on the table, but it was failed miserably. A recording is attached.
"My hands aren't doing what I tell them to do," a tired-sounding woman says on the tape.
Motor delays are reportable. Subject remained fully conscious and responsive throughout testing. The brain waves suggest panic and loss of control. Subject does not have a disability that affects motor control. Hand-eye coordination is getting weaker. Subject hasn't stood up from the chair since the first report of issues.
4 hours after subjects consumed the first dose, subject 6 tried to stand up without assistance, but could not do it without support.
Staff member 12 assisted them, but was met with a sudden involuntary momement. Subject made contact with the staff member's arm using teeth. Skin was broken. Minor bleeding observed. No serious harm was done.
Subject immediately expressed distress following the incident. Following recording is attached.
"I didn't mean to do that. I just couldn't stop myself," the deep male voice says in the audio. The audio ends with a scream in the background.
Subject was put through more tests on this. There was nothing wrong with any part of subject's brain. Subject showed no later signs of aggression. The loss of motor control is clasified as an atypical motor response, and is expected not to happen again. Current working hypothesis classifies incident to stress response combined with side effects.
Similar symptoms have not been widely replicated across other subjects. Loss of motor control effect remains within acceptable thresholds for trial period. No evidence suggests sustained behavioral risk at this stage. Recommendation is to continue observation under adjusted supevision with a team of safety experts.
Status: Approved for continued development.